Aspen Aerogels (NYSE: ASPN) reported Q3 EPS of ($0.25), $0.09 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $24.2 million versus the consensus estimate of $26.28 million.

For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.